A mother’s gut microbes share genes with bacteria in the infant gut

A mother’s microbiota may shape the infant gut microbiota through horizontal gene transfer, in addition to the classical transmission of maternal bacteria to the infant’s gut.

Gut microbes may regulate motivation to exercise

The findings of a recent study suggest that signals derived from the gut can boost the motivation to exercise.

Christoph Lacroix: “Bifidobacteria are critical for microbiota development in infants”

According to Christoph Lacroix (ETH Zurich), bifidobacteria are critical in the development of the neonatal microbiota. Here's why.

A Phase 3 LBP To Treat Acute Graft-versus-Host-Disease

Savita Bernal, Chief Business Officer at MaaT Pharma, discussed the Phase 3 trial (ARES) in patients with acute Graft-versus-Host-Disease with gastrointestinal involvement.

Christine Moissl Eichinger: changes in the microbiota of astronauts on space missions

Christine Moissl-Eichinger (Medical University of Graz, Austria) explains the changes in the microbiome of astronauts.

General Biomics and The Jackson Laboratory announce intellectual property licensing agreement

The agreement will aid in the understanding of the microbiome in human disease.

Gut microbes may help keep the blood-cerebrospinal fluid barrier intact

A recent study suggests that the blood-cerebrospinal fluid barrier is another barrier along the gut-brain axis that is likely influenced by the gut microbiota.

Microbiotas are transmitted between people that spend time together

A recent study suggests that people who spend time together share similar gut microbiotas — with some microbes being largely transmitted between friends and relatives.

Food and Food Supplements: As Italy, France Will Allow the Use of the Term ‘Probiotic’ Under Certain Conditions

The DGCCRF has announced that the use of the word “probiotic” can be allowed on the label of dietary supplements, as well as the health claim “contributes to the balance…

The Future of Microbiome Modulation Immuno-Oncology

Fabio Grassi, Founder at MV BioTherapeutics SA, discussed how to understand the mechanisms of action for microbiome contributions to cancer therapeutic response in patients.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top